The current once-weekly subcutaneous injection model works, but once-monthly or even implantable formulations are on the horizon
Current understanding of COPD pathogenesis primarily focuses on airway inflammation, immune dysfunction, oxidative stress, and protease-antiprotease imbalance
The escalating combinations: High CYP1B1 activity + null GSTM1/GSTT1: CYP1B1 Leu432Val high-activity variants increase 4-OHE2 production from estradiol providing more reactive substrate for quinone formation
This blog post was originally written by Preet Bhinder, MD and published at nootralize.com, it is not a substitute for professional medical advice, diagnosis, or treatment
39,400 ~ 7,000 ( 46,400) ( ) 3 1 46,400 + 7,000 11pay 170P als71231 47,900 + 11pay 170P 49,400 + 7,000 11pay 170P (3) (0) ,
May 2013;31(5):952-959